Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
35 studies found for:    " July 24, 2013":" August 23, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" July 24, 2013":" August 23, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B
Condition: HIV Infections
Intervention: Biological: Experimental
2 Completed Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen
Condition: HIV Disease
Intervention: Drug: Stribild (elvitegravir, cobicistat, emtricitabine and tenofovir)
3 Unknown  IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection
Condition: HIV Reservoirs
Intervention: Other: Blood sample and recto-colic biopsies
4 Recruiting Study of Immune Responses Induced by a HIV Vaccine
Condition: HIV Infections
Interventions: Biological: AIDSVAX B/E;   Biological: AIDSVAX B/E Placebo
5 Active, not recruiting Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: ALVAC-HIV Placebo;   Biological: AIDSVAX B/E Placebo
6 Withdrawn Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo for DNA/NYVAC/AIDSVAX
7 Withdrawn Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications
Condition: HIV Infections
Interventions: Biological: GEO-D03 DNA Vaccine;   Biological: MVA/HIV62B Vaccine;   Biological: Placebo for DNA GEO-D03;   Biological: Placebo for MVA/HIV62B Vaccine
8 Completed Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique
Condition: HIV-positive
Intervention: Behavioral: SMS reminders
9 Completed
Has Results
A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)
Condition: HIV Infections
Interventions: Drug: Raltegravir (ISENTRESS™);   Drug: MAALOX (MAL)
10 Recruiting A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives
Condition: HIV
Interventions: Behavioral: Prevention & Testing;   Behavioral: Prevention & Testing Control
11 Unknown  Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire
Condition: HIV Infection
Intervention:
12 Active, not recruiting Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: EVG;   Drug: Background regimen
13 Recruiting Maternal HIV: Trial to Assist Disclosure to Children
Condition: HIV
Intervention: Behavioral: TRACK Intervention
14 Completed X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study
Condition: Hiv Infection
Intervention: Biological: A peripheral blood sample
15 Completed Juvenile Detention to Community Life
Conditions: Substance Use;   Delinquency;   Risk for HIV Infection
Interventions: Behavioral: Multidimensional Family Therapy Cross-Systems;   Behavioral: Enhanced Services as Usual
16 Unknown  The ACCLAIM Project
Condition: HIV
Interventions: Behavioral: Community leader engagement;   Behavioral: Community days;   Behavioral: Community Peer Groups
17 Active, not recruiting ENGAGE4HEALTH: A Combination Intervention Strategy for Linkage and Retention in Mozambique
Condition: HIV
Interventions: Other: Point of care CD4+ after HIV diagnosis;   Other: Accelerated ART initiation;   Behavioral: SMS appointment reminders;   Other: Non-cash Financial Incentives
18 Active, not recruiting Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART Study
Condition: HIV
Intervention: Other: MCH-focused ART services
19 Recruiting HBV-HIV Coinfection Research Network
Conditions: Hepatitis B;   Human Immunodeficiency Virus
Intervention:
20 Active, not recruiting
Has Results
A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir/abacavir/lamivudine FDC;   Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir/emtricitabine FDC

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.